These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 36066893)

  • 21. Patient impressions of the impact of comorbidities on lung cancer screening benefits and harms: A qualitative analysis.
    Kale MS; Diefenbach M; Masse S; Kee D; Schnur J
    Patient Educ Couns; 2023 Mar; 108():107590. PubMed ID: 36528981
    [TBL] [Abstract][Full Text] [Related]  

  • 22. "It Can't Hurt!": Why Many Patients With Limited Life Expectancy Decide to Accept Lung Cancer Screening.
    Núñez ER; Bolton RE; Boudreau JH; Sliwinski SK; Herbst AN; Kearney LE; Caverly TJ; Wiener RS
    Ann Fam Med; 2024; 22(2):95-102. PubMed ID: 38527813
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Real-World Lung Cancer CT Screening Performance, Smoking Behavior, and Adherence to Recommendations: Lung-RADS Category and Smoking Status Predict Adherence.
    Barbosa EJM; Yang R; Hershman M
    AJR Am J Roentgenol; 2021 Apr; 216(4):919-926. PubMed ID: 32755178
    [No Abstract]   [Full Text] [Related]  

  • 24. Personalised Lung Cancer Screening (PLuS) study to assess the importance of coexisting chronic conditions to clinical practice and policy: protocol for a multicentre observational study.
    Braithwaite D; Karanth SD; Slatore CG; Zhang D; Bian J; Meza R; Jeon J; Tammemagi M; Schabath M; Wheeler M; Guo Y; Hochhegger B; Kaye FJ; Silvestri GA; Gould MK
    BMJ Open; 2022 Jun; 12(6):e064142. PubMed ID: 35732383
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factors Associated With Nonadherence to Lung Cancer Screening Across Multiple Screening Time Points.
    Lin Y; Liang LJ; Ding R; Prosper AE; Aberle DR; Hsu W
    JAMA Netw Open; 2023 May; 6(5):e2315250. PubMed ID: 37227725
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Patterns and Factors Associated With Adherence to Lung Cancer Screening in Diverse Practice Settings.
    Sakoda LC; Rivera MP; Zhang J; Perera P; Laurent CA; Durham D; Huamani Velasquez R; Lane L; Schwartz A; Quesenberry CP; Minowada G; Henderson LM
    JAMA Netw Open; 2021 Apr; 4(4):e218559. PubMed ID: 33929519
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lung Cancer Screening Decision Aid Designed for a Primary Care Setting: A Randomized Clinical Trial.
    Schapira MM; Hubbard RA; Whittle J; Vachani A; Kaminstein D; Chhatre S; Rodriguez KL; Bastian LA; Kravetz JD; Asan O; Prigge JM; Meline J; Schrand S; Ibarra JV; Dye DA; Rieder JB; Frempong JO; Fraenkel L
    JAMA Netw Open; 2023 Aug; 6(8):e2330452. PubMed ID: 37647070
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lung Cancer Screening: Characteristics of Nonparticipants and Potential Screening Barriers.
    Raju S; Khawaja A; Han X; Wang X; Mazzone PJ
    Clin Lung Cancer; 2020 Sep; 21(5):e329-e336. PubMed ID: 32371161
    [TBL] [Abstract][Full Text] [Related]  

  • 29. What factors do patients consider most important in making lung cancer screening decisions? Findings from a demonstration project conducted in the Veterans Health Administration.
    Lillie SE; Fu SS; Fabbrini AE; Rice KL; Clothier B; Nelson DB; Doro EA; Moughrabieh MA; Partin MR
    Lung Cancer; 2017 Feb; 104():38-44. PubMed ID: 28212998
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of Incidental Findings Information on Lung Cancer Screening Intent: a Randomized Controlled Trial.
    Clark SD; Reuland DS; Brenner AT; Jonas DE
    J Gen Intern Med; 2022 Nov; 37(14):3676-3683. PubMed ID: 35113322
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lung cancer screening use and implications of varying eligibility criteria by race and ethnicity: 2019 Behavioral Risk Factor Surveillance System data.
    Williams RM; Li T; Luta G; Wang MQ; Adams-Campbell L; Meza R; Tammemägi MC; Taylor KL
    Cancer; 2022 May; 128(9):1812-1819. PubMed ID: 35201610
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lung Cancer Screening in Clinical Practice: A 5-Year Review of Frequency and Predictors of Lung Cancer in the Screened Population.
    Lafata KJ; Read C; Tong BC; Akinyemiju T; Wang C; Cerullo M; Tailor TD
    J Am Coll Radiol; 2024 May; 21(5):767-777. PubMed ID: 37952807
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Individual decision making about lung cancer screening: A conjoint analysis of perspectives among a high-risk national sample.
    Byrne MM; Thurer RJ; Studts JL
    Cancer Med; 2019 Sep; 8(12):5779-5786. PubMed ID: 31385463
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of lung cancer risk and comorbidity in lung cancer screening use.
    Richman IB; Long JB; Poghosyan H; Sather P; Gross CP
    Prev Med Rep; 2022 Dec; 30():102006. PubMed ID: 36203942
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The tobacco quitline setting as a teachable moment: The Educating Quitline Users About Lung (EQUAL) cancer screening randomized trial.
    Webster M; Whealan J; Williams RM; Eyestone E; Le A; Childs J; Kao JY; Martin M; Wolfe S; Yang F; Hung PY; Lau YK; Luta G; Tammemagi M; Meza R; Taylor KL
    Transl Behav Med; 2023 Sep; 13(10):736-747. PubMed ID: 37616531
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Using Community Health Advisors to Increase Lung Cancer Screening Awareness in the Black Belt: a Pilot Study.
    Niranjan SJ; Opoku-Agyeman W; Hardy CM; Bowman T; Vedre-Kyanam A; Hearld KR; Dransfield MT; Baskin ML
    J Cancer Educ; 2023 Aug; 38(4):1286-1295. PubMed ID: 36650394
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Racial Differences in Adherence to Lung Cancer Screening Follow-up: A Systematic Review and Meta-analysis.
    Kunitomo Y; Bade B; Gunderson CG; Akgün KM; Brackett A; Cain H; Tanoue L; Bastian LA
    Chest; 2022 Jan; 161(1):266-275. PubMed ID: 34390706
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The association of urbanicity and travel time with lung cancer screening utilization.
    Melikam ES; Simmons V; Masoomkhah E; Franco R; Cartmell KB; Mayo R; Gimbel R; Okon M; Zhang L
    Cancer Epidemiol; 2023 Aug; 85():102396. PubMed ID: 37290246
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Individual- and neighborhood-level characteristics of lung cancer screening participants undergoing telemedicine shared decision making.
    Shusted CS; Juon HS; Ruane B; Till B; Zeigler-Johnson C; McIntire RK; Grenda T; Okusanya O; Evans NR; Kane GC; Barta JA
    BMC Health Serv Res; 2023 Oct; 23(1):1179. PubMed ID: 37899430
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.